Surface-modified PLGA-based nanoparticles that can efficiently associate and deliver virus-like particles

Nanomedicine

Volumn 5, Issue 6, 2010, Pages 843-853

  Paolicelli, Patrizia ^a   Prego, Cecilia ^a   Sanchez, Alejandro ^a   Alonso, Maria J ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

PLGA based nanoparticle; rHBsAg; surface modification; vaccine delivery; virus like particle

Indexed keywords

CHITOSAN; NANOCARRIER; NANOPARTICLE; POLOXAMER; POLYGLACTIN; POLYGLACTIN NANOPARTICLE; RECOMBINANT HEPATITIS B VACCINE; UNCLASSIFIED DRUG;

ANTIGENICITY; ARTICLE; BIODEGRADABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FREEZE DRYING; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; VIRUS LIKE AGENT; WESTERN BLOTTING;

LACTIC ACID; NANOPARTICLES; POLYGLYCOLIC ACID; SURFACE PROPERTIES; VIRION;

EID: 77956092608     PISSN: 17435889     EISSN: None     Source Type: Journal    
DOI: 10.2217/nnm.10.69     Document Type: Article

References (22)

1. Csaba N, Garcia-Fuentes M, Alonso MJ: Nanoparticles for nasal vaccination. Adv. Drug Deliv. Rev. 61, 140-157 (2009).
2. Peek LJ, Middaugh CR, Berkland C: Nanotechnology in vaccine delivery. Adv. Drug Deliv. Rev. 60, 915-928 (2008).
3. Jiang W, Gupta RK, Deshpande MC, Schwendeman SP: Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv. Drug Deliv. Rev. 57, 391-410 (2005).
4. Alonso MJ, Cohen S, Park TG, Gupta RK, Siber RG, Langer R: Determinants of release rate of tetanus vaccine from polyester microspheres. Pharm. Res. 10, 945-953
5. Alonso MJ, Gupta RK, Min C, Siber GR, Langer R: Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine 12, 299-306
6. Schwendeman SP, Costantino HR, Gupta RK et al.: Strategies for stabilising tetanus toxoid towards the development of a single-dose tetanus vaccine. Dev. Biol. Stand. 87, 293-306 (1996).
7. Xing DKL, Crane DT, Bolgiano B, Corbel MJ, Jones C, Sesardic D: Physicochemical and immunological studies on the stability of free and microsphere-encapsulated tetanus toxoid in vitro. Vaccine 14, 1205-1213 (1996).
8. Tobio M, Nolley J, Guo Y, McIver J, Alonso MJ: A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle. Pharm. Res. 16, 682-688 (1999).
9. Tobio M, Schwendeman SP, Guo Y, Mclver J, Langer R, Alonso MJ: Improved immunogenicity of a core-coated tetanus toxoid delivery system. Vaccine 12, 618-622 (1999).
10. Sanchez A, Villamayor B, Guo Y, Mclver J, Alonso MJ: Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres. Int. J. Pharm. 185, 255-266
11. Vila A, Sanchez A, Calvo P, Tobio M, Alonso MJ: Design of biodegradable particles for protein delivery. J. Control. Release 78, 15-24 (2002).
12. Vila A, Sanchez A, Evora C, Soriano I, McCallion O, Alonso MJ: PLA-PEG particles as nasal protein carriers: the influence of the particle size. Int. J. Pharm. 292, 43-52 (2005).
13. Tobio M, Sanchez A, Vila A et al.: The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration. Colloids Surf. B Biointerfaces 18, 315-323 (2000)
14. Tobio M, Gref R, Sanchez A, Langer R, Alonso MJ: Stealth PLA-PEG nanoparticles as protein carriers for nasal administration. Pharm. Res. 15, 270-275 (1998).
15. Csaba N, Gonzalez L, Sanchez A, Alonso MJ: Design and characterisation of new nanoparticulate polymer blends for drug delivery. J. Biomater. Sci. Polym. Ed. 15, 1137-1151 (2004).
16. Csaba N, Caamano P, Sanchez A, Dominguez F, Alonso MJ: PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: new carriers for gene delivery. Biomacromol. 6, 271-278 (2005).
17. Csaba N, Sanchez A, Alonso MJ: PLGA:poloxamer and PLGA:poloxamine blend nanostructures as carriers for nasal gene delivery. J. Control. Release. 113, 164-172 (2006).
18. Tleugabulova D: Sodium dodecylsulfate polyacrylamide gel electrophoresis of recombinant hepatitis B surface antigen particles. J. Chromatogr. B Biomed. Sci. Appl. 707, 267-273 (1998).
19. Gavilanes F, Gonzalez-Ros JM, Peterson DL: Structure of hepatitis B surface antigen. J. Biol. Chem. 257, 7770-7777 (1982).
20. Murillo M, Irache JM, Estevan M, Goni MM, Blasco JM, Gamazo C: Influence of the co-encapsulation of different excipients on the properties of polyester microparticle-based vaccine against brucellosis. Int. J. Pharm. 271, 125-135 (2004).
21. Chang AC, Gupta RK: Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen. J. Pharm. Sci. 85, 129-132 (1996).
22. Chacon M, Molpeceres J, Berges L, Guzman M, Aberturas MR: Stability and freeze-drying of cyclosporine loaded poly(D,L-lactide-glycolide) carriers. Eur. J. Pharm. Sci. 8, 99-107 (1999).